SCHEMBL20867062

SCHEMBL20867062

N=C(NC1N=C(c2ccccc2)c2ccccc2NC1=O)OC(=N)c1ccc(N2CCCC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CCKBR P32239 14/20 0.55
▸ CCKAR P32238 10/20 0.55
▸ CBLB Q13191 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20867044 0.93 CBLB (0.55) CCKBRCCKARCBLB
SCHEMBL20866888 0.93 CBLB (0.55) CCKBRCCKARCBLB
SCHEMBL24611894 0.93 CBLB (0.55) CCKBRCCKARCBLB
SCHEMBL21117195 0.92 CCKBR (0.52) CCKBRCCKARCBLB
SCHEMBL20866819 0.88 CCKBR (0.63) CCKBRCCKAR
SCHEMBL24611936 0.86 CCKBR (0.53) CCKBRCCKARCBLB
SCHEMBL20866579 0.85 CCKBR (0.71) CCKBRCCKAR
SCHEMBL20866970 0.85 CCKBR (0.71) CCKBRCCKAR
SCHEMBL24611988 0.85 CBLB (0.51) CCKBRCCKARCBLB
SCHEMBL20867137 0.85 CBLB (0.51) CCKBRCCKARCBLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3324977-B1 BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS ENANTA PHARM INC (US) 2022-07-13 — — EP disclosed
WO-2019067864-A1 COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2019-04-04 — — WO disclosed
Send feedback